Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01CA204302-01A1
Characterization of YAP as a rational companion target in lung cancer
National Institutes of Health
Grant: 5R01CA231300-03
(PQ7) Defining a new mode of RAS signaling in cancer from cytoplasmic protein granules
National Institutes of Health
Grant: 5R01CA211052-03
Optimizing biologically-based rational polytherapy in ALK+ lung cancer
National Institutes of Health
Grant: 3U54CA224081-01S1
Bay Area Team Against Resistance
National Institutes of Health
Grant: 5R01CA169338-02
Rational Combined Inhibition of NF-kB and EGFR to Optimize Lung Cancer Treatment
National Institutes of Health
Grant: 5K08CA222625-02
Therapeutic rescue of the transcriptional repressor Capicua to inhibit lung cancer metastasis
Fields of Study
Keywords
Sustainable Development Goals